Agilent Technologies Exceeds Q3 Street Expectations, Raises Guidance
Agilent Technologies Inc (NYSE: A ) reported third-quarter FY22 revenue growth of 8% year-over-year to $1.72 billion , 13% on a core basis, beating the consensus of $1.61 billion. Revenues for the diagnostics and genomic group decreased 2% Y|Y to $340 million, and the operating margin for the quarter was 21.5%. Revenues for the life sciences and applied markets group increased 14% to $1.02 billion, and revenues for the Agilent … Full story available on Benzinga.com
Agilent Technologies Exceeds Q3 Street Expectations, Raises Guidance
Agilent Technologies Inc (NYSE: A ) reported third-quarter FY22 revenue growth of 8% year-over-year to $1.72 billion , 13% on a core basis, beating the consensus of $1.61 billion. Revenues for the diagnostics and genomic group decreased 2% Y|Y to $340 million, and the operating margin for the quarter was 21.5%. Revenues for the life sciences and applied markets group increased 14% to $1.02 billion, and revenues for the Agilent … Full story available on Benzinga.com